Aller au contenu principal
Profil bibliographique

Shinji Kuriki

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
44Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Hepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus StudiesAutism Spectrum Disorder ResearchHeart Failure Treatment and ManagementCell death mechanisms and regulation

Les publications récentes

Accès ouvert 2026 article OpenAlex

Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

Emi Sometani, Kazuhiro Murai, Hayato Hikita, Jihyun Sung et autres

BACKGROUND AND AIM: Although nucleos(t)ide analog (NUC) therapy reduces hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients, HCC can develop despite viral suppression. Identifying predictive biomarkers of HCC during NUC therapy remains clinically important. This study aimed to identify novel …

jp (code pays fourni par la source)

0 citations Hepatology Research
Accès ouvert 2026 article OpenAlex

Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage

Akiyoshi Shimoda, Kazuhiro Murai, Hayato Hikita, Satoshi Minami et autres

BACKGROUND AND AIM: Hepatitis B surface antigen (HBsAg) is associated with hepatocellular carcinoma risk and immune exhaustion and contributes to hepatitis B virus (HBV) persistence. Current anti-HBV treatments have a limited ability to reduce HBsAg levels. This study aimed to identify FDA-approved …

jp (code pays fourni par la source)

1 citation PLoS ONE
Accès ouvert 2025 article OpenAlex

The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs

Kazuhiro Murai, Hayato Hikita, Ryoko Yamada, Yuki Nishimura et autres

BACKGROUND AND AIM: Nucleos(t)ide analogs (NUCs) are used in the treatment of chronic hepatitis B (CHB). It is still uncertain whether the risk of incident hepatocellular carcinoma (HCC) continues beyond 5 or 10 years after the initiation of NUC treatment. We aimed …

jp (code pays fourni par la source)

7 citations Hepatology Research
Accès ouvert 2023 article OpenAlex

Endoscopic submucosal dissection for early gastric cancer in a patient after left ventricular assist device implantation: A case report

Shinji Kuriki, Yoshiki Tsujii, Hirotsugu Saiki, Takahiro Amano et autres

The use of left ventricular assist device (LVAD) implantation has increased in recent years. Here, we report the first case of gastric endoscopic submucosal dissection (ESD) following LVAD implantation. A 69-year-old man who previously underwent LVAD implantation for severe heart failure underwent …

jp (code pays fourni par la source)

0 citations DEN Open

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.